Cargando…

Mometasone/Indacaterol/Glycopyrronium (MF/IND/GLY) and MF/IND at Different MF Strengths versus Fluticasone Propionate/Salmeterol Xinafoate (FLU/SAL) and FLU/SAL+ Tiotropium in Patients with Asthma

BACKGROUND: Once-daily, single-inhaler mometasone furoate/indacaterol acetate/glycopyrronium bromide (MF/IND/GLY, an ICS/LABA/LAMA) and MF/IND (an ICS/LABA) via Breezhaler(®) have been approved for the maintenance treatment of patients with asthma inadequately controlled with medium-or high-dose ICS...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Zyl-Smit, Richard N, Chapman, Kenneth R, Kerstjens, Huib A M, Gessner, Christian, Sagara, Hironori, Tanase, Ana-Maria, Hosoe, Motoi, Pethe, Abhijit, Lawrence, David, Tillmann, Hanns-Christian, D’Andrea, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880009/ https://www.ncbi.nlm.nih.gov/pubmed/36714049 http://dx.doi.org/10.2147/JAA.S392975

Ejemplares similares

The effect of indacaterol/glycopyrronium versus tiotropium or salmeterol/fluticasone on the prevention of clinically important deterioration in COPD
por: Anzueto, Antonio R, et al.
Publicado: (2017)

MF management
por: Bose, Prithviraj, et al.
Publicado: (2019)

Letter to the editor: indacaterol/glycopyrronium/mometasone furoate compared with salmeterol/fluticasone propionate in patients with asthma: a randomized controlled cross-over study
por: Watz, Henrik, et al.
Publicado: (2020)

Real-life effectiveness of indacaterol–glycopyrronium after switching from tiotropium or salmeterol/fluticasone therapy in patients with symptomatic COPD: the POWER study
por: Kaplan, Alan, et al.
Publicado: (2019)

Efficacy and safety of combined medium-dose mometasone furoate/formoterol (MF/F) in persistent asthmatics
por: Nathan, Robert A, et al.
Publicado: (2010)

Pistia Stratiotes and MF. Malayi
por: Fraser, G.
Publicado: (1938)

One time a day mometasone/indacaterol fixed-dose combination versus two times a day fluticasone/salmeterol in patients with inadequately controlled asthma: pooled analysis from PALLADIUM and IRIDIUM studies
por: Chapman, Kenneth, et al.
Publicado: (2021)

Reproducibility of the mfERG between instruments
por: Harrison, Wendy W., et al.
Publicado: (2009)

Comparing multifocal pupillographic objective perimetry (mfPOP) and multifocal visual evoked potentials (mfVEP) in retinal diseases
por: Sabeti, Faran, et al.
Publicado: (2017)

Microencapsulation of Fluticasone Propionate and Salmeterol Xinafoate in Modified Chitosan Microparticles for Release Optimization
por: Ainali, Nina Maria, et al.
Publicado: (2020)

Lung Function Normalisation with Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate in Patients with Asthma
por: Chapman, Kenneth R., et al.
Publicado: (2021)

Workshops of the MF group in Building 100 at CERN
por: Laurent Guiraud
Publicado: (2000)

Magnetic Field (MF) Applications in Plants: An Overview
por: Sarraf, Mohammad, et al.
Publicado: (2020)

Fasciola spp: Mapping of the MF6 epitope and antigenic analysis of the MF6p/HDM family of heme-binding proteins
por: Martínez-Sernández, Victoria, et al.
Publicado: (2017)

Indacaterol/glycopyrronium is cost-effective compared to salmeterol/fluticasone in COPD: FLAME-based modelling in a Swedish population
por: Bjermer, Leif, et al.
Publicado: (2017)

Indacaterol/glycopyrronium versus salmeterol/fluticasone in the prevention of clinically important deterioration in COPD: results from the FLAME study
por: Anzueto, Antonio R., et al.
Publicado: (2018)

Efficacy of indacaterol/glycopyrronium versus salmeterol/fluticasone in current and ex-smokers: a pooled analysis of IGNITE trials
por: Halpin, David M.G., et al.
Publicado: (2021)

Triple Therapy with Mometasone/Indacaterol/Glycopyrronium or Doubling the ICS/LABA Dose in GINA Step 4: IRIDIUM Analyses
por: van Zyl-Smit, Richard N., et al.
Publicado: (2023)

Efficacy and safety of medium and high doses of mometasone furoate/formoterol (MF/F) combination treatment in subjects with severe persistent asthma
por: Weinstein, Steven F, et al.
Publicado: (2010)

"Neuropatía diabética" HGZ -MF, No.36 I.M.S.S. /
por: Cruz Ahumada, Nivia Doraminta
Publicado: (1996)

RF circuit design techniques for MF-UHF applications
por: Eroglu, Abdullah
Publicado: (2013)

AS03- and MF59-Adjuvanted Influenza Vaccines in Children
por: Wilkins, Amanda L., et al.
Publicado: (2017)

Identification of citrus diseases based on AMSR and MF-RANet
por: Yang, Ruoli, et al.
Publicado: (2022)

Modelling the Cost-Effectiveness of Indacaterol/Glycopyrronium versus Salmeterol/Fluticasone Using a Novel Markov Exacerbation-Based Approach
por: Lakhotia, Bhavesh, et al.
Publicado: (2020)

Indacaterol acetate/mometasone furoate provides sustained improvements in lung function compared with salmeterol xinafoate/fluticasone propionate in patients with moderate-to-very-severe COPD: results from a Phase II randomized, double-blind 12-week study
por: Beeh, Kai Michael, et al.
Publicado: (2018)

Inde : Népal /
por: Deneck, Marie-Madeleine

A Review of the Unique Drug Development Strategy of Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate: A First-in-Class, Once-Daily, Single-Inhaler, Fixed-Dose Combination Treatment for Asthma
por: Brittain, Dominic, et al.
Publicado: (2022)

Fluoro Nitrenoid Complexes FN=MF(2) (M=Co, Rh, Ir): Electronic Structure Dichotomy and Formation of Nitrido Fluorides N≡MF(3)
por: Stüker, Tony, et al.
Publicado: (2020)

The Transcription Factor Twist1 Has a Significant Role in Mycosis Fungoides (MF) Cell Biology: An RNA Sequencing Study of 40 MF Cases
por: Häyrinen, Marjaana J., et al.
Publicado: (2023)

Indacaterol/glycopyrronium versus tiotropium or glycopyrronium in long‐acting bronchodilator‐naïve COPD patients: A pooled analysis
por: Muro, Shigeo, et al.
Publicado: (2019)

Indacaterol/glycopyrronium in symptomatic patients with COPD (GOLD B and GOLD D) versus salmeterol/fluticasone: ILLUMINATE/LANTERN pooled analysis
por: Vogelmeier, Claus, et al.
Publicado: (2016)

Indacaterol/glycopyrronium versus salmeterol/fluticasone in Asian patients with COPD at a high risk of exacerbations: results from the FLAME study
por: Wedzicha, Jadwiga A, et al.
Publicado: (2017)

Antenas verticales para bajas frecuencias (MF y HF)
por: García Domínguez, Armando
Publicado: (2013)

Characterization of the Partitioning System of Myxococcus Plasmid pMF1
por: Sun, Xia, et al.
Publicado: (2011)

MfSAT: Detect simple sequence repeats in viral genomes
por: Chen, Ming, et al.
Publicado: (2011)

mfSBA: Multifractal analysis of spatial patterns in ecological communities
por: Saravia, Leonardo A.
Publicado: (2014)

Fluad®-MF59®-Adjuvanted Influenza Vaccine in Older Adults
por: Tsai, Theodore F
Publicado: (2013)

MF59(®)‐adjuvanted vaccines for seasonal and pandemic influenza prophylaxis
por: Banzhoff, Angelika, et al.
Publicado: (2008)

Investigation of Retinal Spatial Interaction Using mfERG Stimulation
por: Chu, Patrick H. W., et al.
Publicado: (2011)

Effects of Smoothing and Adaptive Filtering in Multifocal Electroretinography (mfERG)
por: Long, Christopher Patrick, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hl83namovtukoiu13np09jg4g4